Supporting Information Simultaneous Electrical Recording of Cardiac Electrophysiology and Contraction on Chip

Prevailing commercialized cardiac platforms for in vitro drug development utilize planar microelectrode arrays to map action potentials, or impedance sensing to record contraction in real time, but cannot record both functions on the same chip with high spatial resolution. Here we report a novel cardiac platform that can record cardiac tissue adhesion, electrophysiology, and contractility on the same chip. The platform integrates two independent yet interpenetrating sensor arrays: a microelectrode array for field potential readouts and an interdigitated electrode array for impedance readouts. Together, these arrays provide real-time, non-invasive data acquisition of both cardiac electrophysiology and contractility under physiological conditions and under drug stimuli. Human induced pluripotent stem cell-derived cardiomyocytes were cultured as a model system, and used to validate the platform with an excitation-contraction decoupling chemical. Preliminary data using the platform to investigate the effect of the drug norepinephrine are combined with computational efforts. This platform provides a quantitative and predictive assay system that can potentially be used for comprehensive assessment of cardiac toxicity earlier in the drug discovery process.

[1]  D. Malan,et al.  Scalable Electrophysiological Investigation of iPS Cell-Derived Cardiomyocytes Obtained by a Lentiviral Purification Strategy , 2015, Journal of clinical medicine.

[2]  M. Watzele,et al.  Dynamic monitoring of beating periodicity of stem cell‐derived cardiomyocytes as a predictive tool for preclinical safety assessment , 2012, British journal of pharmacology.

[3]  Bruno Becker,et al.  Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes. , 2011, Assay and drug development technologies.

[4]  M. Michel,et al.  Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.

[5]  M. Spira,et al.  Multi-electrode array technologies for neuroscience and cardiology. , 2013, Nature nanotechnology.

[6]  R. Kaufmann,et al.  Disorder in Excitation‐Contraction Coupling of Cardiac Muscle from Cats with Experimentally Produced Right Ventricular Hypertrophy , 1971, Circulation research.

[7]  Rona Shofti,et al.  Electromechanical integration of cardiomyocytes derived from human embryonic stem cells , 2004, Nature Biotechnology.

[8]  Yasunari Kanda,et al.  Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology. , 2014, Journal of molecular and cellular cardiology.

[9]  W. Lederer,et al.  Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. , 1997, Science.

[10]  Megan L. McCain,et al.  Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. , 2011, Lab on a chip.

[11]  Kevin E Healy,et al.  In vitro cardiac tissue models: Current status and future prospects. , 2016, Advanced drug delivery reviews.

[12]  Sangyoon J. Han,et al.  Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts. , 2014, Journal of biomechanical engineering.

[13]  K. Boheler,et al.  Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes , 2014, Stem Cell Research & Therapy.

[14]  P. Bergveld,et al.  Theoretical and experimental determination of cell constants of planar-interdigitated electrolyte conductivity sensors , 1995 .

[15]  Lior Gepstein,et al.  Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells , 2009, Circulation.

[16]  R. Shah,et al.  Cardiac Repolarisation and Drug Regulation , 2007, Drug safety.

[17]  D. Huh,et al.  Organs-on-chips at the frontiers of drug discovery , 2015, Nature Reviews Drug Discovery.

[18]  E. Lakatta,et al.  Sarcoplasmic reticulum Ca2+ cycling protein phosphorylation in a physiologic Ca2+ milieu unleashes a high-power, rhythmic Ca2+ clock in ventricular myocytes: relevance to arrhythmias and bio-pacemaker design. , 2014, Journal of molecular and cellular cardiology.

[19]  Clay W Scott,et al.  Human Stem Cell-Derived Cardiomyocytes in Cellular Impedance Assays: Bringing Cardiotoxicity Screening to the Front Line , 2014, Cardiovascular Toxicology.

[20]  Yoram Rudy,et al.  Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca(2+)-transient. , 2011, Journal of molecular and cellular cardiology.

[21]  José Jalife,et al.  Structural heterogeneity promotes triggered activity, reflection and arrhythmogenesis in cardiomyocyte monolayers , 2011, The Journal of physiology.

[22]  William J Polacheck,et al.  Measuring cell-generated forces: a guide to the available tools , 2016, Nature Methods.

[23]  Myrtle Davis,et al.  Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment. , 2016, Journal of pharmacological and toxicological methods.

[24]  F. Abboud,et al.  The effect of norepinephrine on cardiac output, arterial blood pressure, and heart rate in dogs treated with chlorothiazide. , 1962, The Journal of clinical investigation.

[25]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[26]  Chelsey S Simmons,et al.  Microsystems for biomimetic stimulation of cardiac cells. , 2012, Lab on a chip.

[27]  Xin Zhang,et al.  Impedance-based monitoring of ongoing cardiomyocyte death induced by tumor necrosis factor-alpha. , 2009, Biophysical journal.

[28]  Jae Young Lee,et al.  Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development , 2013, Stem Cell Research & Therapy.

[29]  Jürgen Hescheler,et al.  In vitro Model for Assessing Arrhythmogenic Properties of Drugs Based on High-resolution Impedance Measurements , 2012, Cellular Physiology and Biochemistry.

[30]  Andreas Hierlemann,et al.  Impedance characterization and modeling of electrodes for biomedical applications , 2005, IEEE Transactions on Biomedical Engineering.

[31]  Kaiqi Su,et al.  A cardiomyocyte-based biosensor for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and beating. , 2013, Biosensors & bioelectronics.

[32]  Bruce R. Conklin,et al.  A Non-invasive Platform for Functional Characterization of Stem-Cell-Derived Cardiomyocytes with Applications in Cardiotoxicity Testing , 2015, Stem cell reports.

[33]  B. Cui,et al.  Intracellular Recording of Action Potentials by Nanopillar Electroporation , 2012, Nature nanotechnology.

[34]  Adrenergic Regulation of HCN4 Channel Requires Protein Association with β2-Adrenergic Receptor* , 2012, The Journal of Biological Chemistry.

[35]  Mike Clements,et al.  Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  Peter Kohl,et al.  Simultaneous Voltage and Calcium Mapping of Genetically Purified Human Induced Pluripotent Stem Cell–Derived Cardiac Myocyte Monolayers , 2012, Circulation research.

[37]  P. Munch,et al.  Dual Effects of Norepinephrine and Mechanisms of Baroreceptor Stimulation , 1987, Circulation research.

[38]  Alain Lacampagne,et al.  Blebbistatin: use as inhibitor of muscle contraction , 2008, Pflügers Archiv - European Journal of Physiology.

[39]  Jia Liu,et al.  Three-dimensional mapping and regulation of action potential propagation in nanoelectronics innervated tissues , 2016, Nature nanotechnology.